On 14–16 October 2026, Artipelag in Stockholm will host Momentum — a summit convened by the Swedish Cancer Society bringing together a carefully curated group of leaders from across sectors: policymakers, healthcare leaders, patient representatives, researchers, industry and investors, all with a shared ambition to accelerate Europe’s action on cancer.
Across Europe, world-class cancer research discoveries are being made — yet too often they take too long to reach patients. The gap between research, decision-making, and real-world impact remains one of our greatest missed opportunities. Through roundtable discussions and co-creation sessions, participants engage directly with the barriers holding progress back and contribute to shaping solutions. Selected speakers will offer perspectives on key issues such as funding, regulation, data, clinical trials and the uptake of innovation.
As one participant put it: “The bottleneck is time. Every year we spend moving a discovery through regulatory, reimbursement, and clinical trial bureaucracies is a year patients don’t have. The next breakthrough won’t come from a single lab — it will come from collapsing the distance between discovery and patient.”
If you want to be part of shaping a more competitive Europe that delivers faster, better outcomes for patients — this is where that work begins.
Confirmed speakers include:
- Greg Simon, former Executive Director of the White House Cancer Moonshot Task Force
- Elisabete Weiderpass, Director of IARC
- Joanna Drake, Deputy Director-General at the European Commission
- Mihaela van der Schaar, Professor of Machine Learning, AI and Medicine
- Antonella Cardone, CEO of Cancer Patients Europe
- Cary Adams, CEO of UICC
Endorsed by: UICC · EASC · Cancer Patients Europe · IARC, WHO
Early registration deadline: 30 June, 2026
Final registration deadline: 17 August, 2026